Is dual bronchodilation a cost-effective alternative to ICS/LABA in COPD? A Colombian healthcare system evaluation
UMEC/VI is a highly cost-effective alternative to FSC for moderate to severe COPD in Colombia, offering improved clinical outcomes and economic value for resource-constrained health systems.
Authors
- Diana Guerrero Patiño (ORCID: https://orcid.org/0000-0001-7731-4460)
- Jefferson Antonio Buendía (ORCID: https://orcid.org/0000-0003-2404-6612)
Institutions
- Universidad de Antioquia (CO)
Publication Details
- Journal
- Expert Review of Respiratory Medicine
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1080/17476348.2025.2582249
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00